{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-071719","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2023-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.053815+00:00","generated_at":"2026-06-11T02:25:47.108897+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BiomX shareholders approve reverse stock split (1:5-1:10) and 2019 plan amendment","bullets":["Special meeting held August 28, 2023; both proposals passed.","Proposal 1: amendment to 2019 incentive plan to allow option exchanges — 25,795,338 for, 237,665 against.","Proposal 2: authorize board to effect reverse stock split at ratio between 1:5 and 1:10 — 30,686,906 for, 232,624 against.","Proposal 1 had 4,886,229 broker non-votes; Proposal 2 had none."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-071719","json":"https://secwatch.observer/filing/0001213900-23-071719.json","markdown":"https://secwatch.observer/filing/0001213900-23-071719.md","text":"https://secwatch.observer/filing/0001213900-23-071719.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023071719/0001213900-23-071719-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023071719/ea184389-8k_biomxinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:25:47.108897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"47635659e12884dafe401d4a5a90206d5767ec08","claim":"BiomX Inc. shareholders approved Approval of an amendment to the Company's 2019 incentive plan to allow the board to effect one or more option exchanges at the 2023-08-28 meeting.","evidence_excerpt":"Proposal No. 1- Approval of an amendment to the Company's 2019 incentive plan to allow the board to effect one or more option exchanges.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023071719/0001213900-23-071719-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-28"}],"fact_type":"shareholder_vote"},{"claim_id":"6dd853d10dce95674cf940a9d99ce41f06e55c93","claim":"BiomX Inc. shareholders approved Authorization of the Company's board of directors to amend the certificate of incorporation to effect a reverse stock split of the Company's outstanding Common Stock at any ratio between 1-for-5 and 1-for-10 at the 2023-08-28 meeting.","evidence_excerpt":"Proposal No. 2- Authorization of the Company's board of directors to amend the certificate of incorporation to effect a reverse stock split of the Company's outstanding Common Stock at any ratio between 1-for-5 and 1-for-10.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023071719/0001213900-23-071719-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-28"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}